Trial intelligence / Profile preview

Omeprazole for stress ulcer prophylaxis in critically ill ICU patients

TCTR20260116007Phase 4Completed

Sponsor
N/A
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in stress ulcer comparing Omeprazole plus standard of care with Standard of care (2 arms). Primary endpoint: Pneumonia. Started Feb 2023; status: completed.

02

Drugs

omeprazole
03

Conditions

stress ulcer

Beyond the preview

Go deeper on TCTR20260116007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260116007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call